메뉴 건너뛰기




Volumn 6, Issue 4, 2011, Pages

Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 79955550510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018462     Document Type: Article
Times cited : (43)

References (57)
  • 1
    • 67651213097 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2009). CDC website. Available:. Accessed 1 April 2011
    • Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2007. Vol. 19. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (2009). CDC website. Available: http://www.cdc.gov/hiv/surveillance/resources/reports/2007report/pdf/cover.pdf. Accessed 1 April 2011.
    • (2009) HIV/AIDS Surveillance Report, 2007 , vol.19
  • 2
    • 50849102341 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, HIV/AIDS Surveillance Supplemental Report (2008). CDC website. Available:. Accessed 1 April 2011
    • Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in urban and rural areas of the United States, 2006. HIV/AIDS Surveillance Supplemental Report (2008). CDC website. Available: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2008supp_vol13no2/pdf/HIVAIDS_SSR_Vol13_No2.pdf. Accessed 1 April 2011.
    • (2006) Cases of HIV infection and AIDS in urban and rural areas of the United States
  • 3
    • 76649092701 scopus 로고    scopus 로고
    • UNAIDS, UNAIDS website. Available:. Accessed 1 April 2011
    • UNAIDS 2008 Report on the global AIDS epidemic. UNAIDS website. Available: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/. Accessed 1 April 2011.
    • (2008) Report on the global AIDS epidemic
  • 4
    • 84887212498 scopus 로고    scopus 로고
    • Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004
    • Grigoryan A, Hall HI, Durant T, Wei X, (2009) Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One 4: e4445.
    • (2009) PLoS One , vol.4
    • Grigoryan, A.1    Hall, H.I.2    Durant, T.3    Wei, X.4
  • 5
    • 2642709177 scopus 로고    scopus 로고
    • Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
    • Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
    • (1998) N Engl J Med , vol.338 , pp. 853-860
    • Palella Jr., F.J.1    Delaney, K.M.2    Moorman, A.C.3    Loveless, M.O.4    Fuhrer, J.5
  • 6
    • 0038162585 scopus 로고    scopus 로고
    • Decline in the AIDS and death rates in the EuroSIDA study: an observational study
    • Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, et al. (2003) Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362: 22-29.
    • (2003) Lancet , vol.362 , pp. 22-29
    • Mocroft, A.1    Ledergerber, B.2    Katlama, C.3    Kirk, O.4    Reiss, P.5
  • 7
    • 0037013038 scopus 로고    scopus 로고
    • Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
    • Hogg RS, Heath K, Bangsberg D, Yip B, Press N, et al. (2002) Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 16: 1051-1058.
    • (2002) AIDS , vol.16 , pp. 1051-1058
    • Hogg, R.S.1    Heath, K.2    Bangsberg, D.3    Yip, B.4    Press, N.5
  • 8
    • 0038502358 scopus 로고    scopus 로고
    • Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study
    • Lucas GM, Chaisson RE, Moore RD, (2003) Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study. J Acquir Immune Defic Syndr 33: 321-328.
    • (2003) J Acquir Immune Defic Syndr , vol.33 , pp. 321-328
    • Lucas, G.M.1    Chaisson, R.E.2    Moore, R.D.3
  • 9
    • 79551600980 scopus 로고    scopus 로고
    • Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research
    • Bae JW, Guyer W, Grimm K, Altice FL, (2011) Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS 25: 279-290.
    • (2011) AIDS , vol.25 , pp. 279-290
    • Bae, J.W.1    Guyer, W.2    Grimm, K.3    Altice, F.L.4
  • 10
    • 0036408650 scopus 로고    scopus 로고
    • A prospective study of predictors of adherence to combination antiretroviral medication
    • Golin CE, Liu H, Hays RD, Miller LG, Beck CK, et al. (2002) A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 17: 756-765.
    • (2002) J Gen Intern Med , vol.17 , pp. 756-765
    • Golin, C.E.1    Liu, H.2    Hays, R.D.3    Miller, L.G.4    Beck, C.K.5
  • 12
    • 0038731023 scopus 로고    scopus 로고
    • Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection
    • Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL, (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med 114: 573-580.
    • (2003) Am J Med , vol.114 , pp. 573-580
    • Tucker, J.S.1    Burnam, M.A.2    Sherbourne, C.D.3    Kung, F.Y.4    Gifford, A.L.5
  • 13
    • 0035392933 scopus 로고    scopus 로고
    • Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection
    • Lucas GM, Cheever LW, Chaisson RE, Moore RD, (2001) Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 27: 251-259.
    • (2001) J Acquir Immune Defic Syndr , vol.27 , pp. 251-259
    • Lucas, G.M.1    Cheever, L.W.2    Chaisson, R.E.3    Moore, R.D.4
  • 14
    • 0036282710 scopus 로고    scopus 로고
    • Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users
    • Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, et al. (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17: 377-381.
    • (2002) J Gen Intern Med , vol.17 , pp. 377-381
    • Arnsten, J.H.1    Demas, P.A.2    Grant, R.W.3    Gourevitch, M.N.4    Farzadegan, H.5
  • 15
    • 38849145634 scopus 로고    scopus 로고
    • HIV medication adherence and substance use: The Smartest Women's Project
    • Lopez E, Jones DL, Ishii M, Tobin JN, Weiss SM, (2007) HIV medication adherence and substance use: The Smartest Women's Project. Am J Infect Dis 3: 240-247.
    • (2007) Am J Infect Dis , vol.3 , pp. 240-247
    • Lopez, E.1    Jones, D.L.2    Ishii, M.3    Tobin, J.N.4    Weiss, S.M.5
  • 17
    • 29144444035 scopus 로고    scopus 로고
    • Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
    • Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, et al. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20: 73-83.
    • (2006) AIDS , vol.20 , pp. 73-83
    • Freeman, E.E.1    Weiss, H.A.2    Glynn, J.R.3    Cross, P.L.4    Whitworth, J.A.5
  • 18
    • 56749131188 scopus 로고    scopus 로고
    • Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial
    • Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, et al. (2008) Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 198: 1804-1808.
    • (2008) J Infect Dis , vol.198 , pp. 1804-1808
    • Baeten, J.M.1    Strick, L.B.2    Lucchetti, A.3    Whittington, W.L.4    Sanchez, J.5
  • 19
    • 0027261005 scopus 로고
    • HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack
    • Booth RE, Watters JK, Chitwood DD, (1993) HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 83: 1144-1148.
    • (1993) Am J Public Health , vol.83 , pp. 1144-1148
    • Booth, R.E.1    Watters, J.K.2    Chitwood, D.D.3
  • 20
    • 0742266707 scopus 로고    scopus 로고
    • The role of sexual transmission of HIV infection among injection and non-injection drug users
    • Strathdee SA, Sherman SG, (2003) The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 80: iii7-14.
    • (2003) J Urban Health , vol.80
    • Strathdee, S.A.1    Sherman, S.G.2
  • 21
    • 70349204028 scopus 로고    scopus 로고
    • Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample
    • Cavazos-Rehg PA, Spitznagel EL, Schootman M, Strickland JR, Afful SE, et al. (2009) Risky sexual behaviors and sexually transmitted diseases: a comparison study of cocaine-dependent individuals in treatment versus a community-matched sample. AIDS Patient Care STDS 23: 727-734.
    • (2009) AIDS Patient Care STDS , vol.23 , pp. 727-734
    • Cavazos-Rehg, P.A.1    Spitznagel, E.L.2    Schootman, M.3    Strickland, J.R.4    Afful, S.E.5
  • 22
    • 0023915568 scopus 로고
    • Morphine pellet-induced immunomodulation in mice: temporal relationships
    • Bryant HU, Bernton EW, Holaday JW, (1988) Morphine pellet-induced immunomodulation in mice: temporal relationships. J Pharmacol Exp Ther 245: 913-920.
    • (1988) J Pharmacol Exp Ther , vol.245 , pp. 913-920
    • Bryant, H.U.1    Bernton, E.W.2    Holaday, J.W.3
  • 23
    • 0027379756 scopus 로고
    • Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity
    • Carr DJ, Gebhardt BM, Paul D, (1993) Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 264: 1179-1186.
    • (1993) J Pharmacol Exp Ther , vol.264 , pp. 1179-1186
    • Carr, D.J.1    Gebhardt, B.M.2    Paul, D.3
  • 24
    • 0032520702 scopus 로고    scopus 로고
    • Acute and chronic effects of cocaine on the immune system and the possible link to AIDS
    • Baldwin GC, Roth MD, Tashkin DP, (1998) Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 83: 133-138.
    • (1998) J Neuroimmunol , vol.83 , pp. 133-138
    • Baldwin, G.C.1    Roth, M.D.2    Tashkin, D.P.3
  • 25
    • 0033051242 scopus 로고    scopus 로고
    • Cocaine effects on immunocompetent cells: an observation of in vitro cocaine exposure
    • Xu W, Flick T, Mitchel J, Knowles C, Ault K, (1999) Cocaine effects on immunocompetent cells: an observation of in vitro cocaine exposure. Int J Immunopharmacol 21: 463-472.
    • (1999) Int J Immunopharmacol , vol.21 , pp. 463-472
    • Xu, W.1    Flick, T.2    Mitchel, J.3    Knowles, C.4    Ault, K.5
  • 26
    • 0036499023 scopus 로고    scopus 로고
    • Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes
    • Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, et al. (2002) Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 185: 701-705.
    • (2002) J Infect Dis , vol.185 , pp. 701-705
    • Roth, M.D.1    Tashkin, D.P.2    Choi, R.3    Jamieson, B.D.4    Zack, J.A.5
  • 27
    • 33747365020 scopus 로고    scopus 로고
    • Drugs of abuse, immune modulation, and AIDS
    • Cabral GA, (2006) Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol 1: 280-295.
    • (2006) J Neuroimmune Pharmacol , vol.1 , pp. 280-295
    • Cabral, G.A.1
  • 28
    • 0032511413 scopus 로고    scopus 로고
    • Barriers to use of free antiretroviral therapy in injection drug users
    • Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, et al. (1998) Barriers to use of free antiretroviral therapy in injection drug users. JAMA 280: 547-549.
    • (1998) JAMA , vol.280 , pp. 547-549
    • Strathdee, S.A.1    Palepu, A.2    Cornelisse, P.G.3    Yip, B.4    O'Shaughnessy, M.V.5
  • 29
    • 0033572220 scopus 로고    scopus 로고
    • Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors
    • Murri R, Fantoni M, Del Borgo C, Izzi I, Visona R, et al. (1999) Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. J Acquir Immune Defic Syndr 22: 461-466.
    • (1999) J Acquir Immune Defic Syndr , vol.22 , pp. 461-466
    • Murri, R.1    Fantoni, M.2    Del Borgo, C.3    Izzi, I.4    Visona, R.5
  • 30
    • 0035823013 scopus 로고    scopus 로고
    • Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
    • Celentano DD, Galai N, Sethi AK, Shah NG, Strathdee SA, et al. (2001) Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 15: 1707-1715.
    • (2001) AIDS , vol.15 , pp. 1707-1715
    • Celentano, D.D.1    Galai, N.2    Sethi, A.K.3    Shah, N.G.4    Strathdee, S.A.5
  • 31
    • 33748750443 scopus 로고    scopus 로고
    • Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain
    • Rodriguez-Arenas MA, Jarrin I, Del Amo J, Iribarren JA, Moreno S, et al. (2006) Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses 22: 715-723.
    • (2006) AIDS Res Hum Retroviruses , vol.22 , pp. 715-723
    • Rodriguez-Arenas, M.A.1    Jarrin, I.2    Del Amo, J.3    Iribarren, J.A.4    Moreno, S.5
  • 32
    • 0035876449 scopus 로고    scopus 로고
    • Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy
    • Poundstone KE, Chaisson RE, Moore RD, (2001) Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 15: 1115-1123.
    • (2001) AIDS , vol.15 , pp. 1115-1123
    • Poundstone, K.E.1    Chaisson, R.E.2    Moore, R.D.3
  • 33
    • 0346729948 scopus 로고    scopus 로고
    • Differences in HIV disease progression by injecting drug use in HIV-infected persons in care
    • Moore RD, Keruly JC, Chaisson RE, (2004) Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr 35: 46-51.
    • (2004) J Acquir Immune Defic Syndr , vol.35 , pp. 46-51
    • Moore, R.D.1    Keruly, J.C.2    Chaisson, R.E.3
  • 34
    • 0035999653 scopus 로고    scopus 로고
    • The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study
    • Galvan FH, Bing EG, Fleishman JA, London AS, Caetano R, et al. (2002) The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 63: 179-186.
    • (2002) J Stud Alcohol , vol.63 , pp. 179-186
    • Galvan, F.H.1    Bing, E.G.2    Fleishman, J.A.3    London, A.S.4    Caetano, R.5
  • 35
    • 33646790204 scopus 로고    scopus 로고
    • Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy
    • Chander G, Himelhoch S, Moore RD, (2006) Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs 66: 769-789.
    • (2006) Drugs , vol.66 , pp. 769-789
    • Chander, G.1    Himelhoch, S.2    Moore, R.D.3
  • 36
    • 49849094871 scopus 로고    scopus 로고
    • Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women
    • Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, et al. (2008) Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22: 1355-1363.
    • (2008) AIDS , vol.22 , pp. 1355-1363
    • Cook, J.A.1    Burke-Miller, J.K.2    Cohen, M.H.3    Cook, R.L.4    Vlahov, D.5
  • 37
    • 64249165706 scopus 로고    scopus 로고
    • Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users
    • Baum MK, Rafie C, Lai S, Sales S, Page B, et al. (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 50: 93-99.
    • (2009) J Acquir Immune Defic Syndr , vol.50 , pp. 93-99
    • Baum, M.K.1    Rafie, C.2    Lai, S.3    Sales, S.4    Page, B.5
  • 38
    • 33645081756 scopus 로고    scopus 로고
    • Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy
    • Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, et al. (2006) Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy. Am J Epidemiol 163: 412-420.
    • (2006) Am J Epidemiol , vol.163 , pp. 412-420
    • Lucas, G.M.1    Griswold, M.2    Gebo, K.A.3    Keruly, J.4    Chaisson, R.E.5
  • 39
    • 0029094558 scopus 로고
    • Race, sex, drug use, and progression of human immunodeficiency virus disease
    • Chaisson RE, Keruly JC, Moore RD, (1995) Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J Med 333: 751-756.
    • (1995) N Engl J Med , vol.333 , pp. 751-756
    • Chaisson, R.E.1    Keruly, J.C.2    Moore, R.D.3
  • 40
    • 18744438088 scopus 로고    scopus 로고
    • Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort
    • Moore RD, (1998) Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort. J Acquir Immune Defic Syndr Hum Retrovirol 17 (Suppl 1): S38-S41.
    • (1998) J Acquir Immune Defic Syndr Hum Retrovirol , vol.17 , Issue.SUPPL. 1 , pp. 38-41
    • Moore, R.D.1
  • 41
    • 0034604276 scopus 로고    scopus 로고
    • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
    • Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133: 21-30.
    • (2000) Ann Intern Med , vol.133 , pp. 21-30
    • Paterson, D.L.1    Swindells, S.2    Mohr, J.3    Brester, M.4    Vergis, E.N.5
  • 43
    • 9644310624 scopus 로고    scopus 로고
    • National Institute on Drug Abuse. Community Epidemiology Work Group, NIDA website. Available at, Accessed 1 April 2011
    • National Institute on Drug Abuse. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse, 2006. NIDA website. Available at: http://www.drugabuse.gov/PDF/CEWG/Vol1_106.pdf. Accessed 1 April 2011.
    • (2006) Epidemiologic Trends in Drug Abuse
  • 44
    • 33645017411 scopus 로고    scopus 로고
    • Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
    • Braitstein P, Justice A, Bangsberg DR, Yip B, Alfonso V, et al. (2006) Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS 20: 323-331.
    • (2006) AIDS , vol.20 , pp. 323-331
    • Braitstein, P.1    Justice, A.2    Bangsberg, D.R.3    Yip, B.4    Alfonso, V.5
  • 45
    • 0034662733 scopus 로고    scopus 로고
    • Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?
    • Mocroft A, Gill MJ, Davidson W, Phillips AN, (2000) Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr 24: 475-482.
    • (2000) J Acquir Immune Defic Syndr , vol.24 , pp. 475-482
    • Mocroft, A.1    Gill, M.J.2    Davidson, W.3    Phillips, A.N.4
  • 47
    • 67651167081 scopus 로고    scopus 로고
    • Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy
    • Silverberg MJ, Jacobson LP, French AL, Witt MD, Gange SJ, (2009) Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage 38: 197-207.
    • (2009) J Pain Symptom Manage , vol.38 , pp. 197-207
    • Silverberg, M.J.1    Jacobson, L.P.2    French, A.L.3    Witt, M.D.4    Gange, S.J.5
  • 48
    • 67349156426 scopus 로고    scopus 로고
    • Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators
    • Shepherd BE, Sterling TR, Moore RD, Raffanti SP, Hulgan T, (2009) Cross-cohort heterogeneity encountered while validating a model for HIV disease progression among antiretroviral initiators. J Clin Epidemiol 62: 729-737.
    • (2009) J Clin Epidemiol , vol.62 , pp. 729-737
    • Shepherd, B.E.1    Sterling, T.R.2    Moore, R.D.3    Raffanti, S.P.4    Hulgan, T.5
  • 49
    • 0035915372 scopus 로고    scopus 로고
    • Structured treatment interruptions for the management of HIV infection
    • Lori F, Lisziewicz J, (2001) Structured treatment interruptions for the management of HIV infection. JAMA 286: 2981-2987.
    • (2001) JAMA , vol.286 , pp. 2981-2987
    • Lori, F.1    Lisziewicz, J.2
  • 50
    • 0033402880 scopus 로고    scopus 로고
    • Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study
    • Junghans C, Low N, Chan P, Witschi A, Vernazza P, et al. (1999) Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS 13: 2547-2554.
    • (1999) AIDS , vol.13 , pp. 2547-2554
    • Junghans, C.1    Low, N.2    Chan, P.3    Witschi, A.4    Vernazza, P.5
  • 51
    • 0033452198 scopus 로고    scopus 로고
    • A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival
    • Mocroft A, Madge S, Johnson AM, Lazzarin A, Clumeck N, et al. (1999) A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival. J Acquir Immune Defic Syndr 22: 369-378.
    • (1999) J Acquir Immune Defic Syndr , vol.22 , pp. 369-378
    • Mocroft, A.1    Madge, S.2    Johnson, A.M.3    Lazzarin, A.4    Clumeck, N.5
  • 52
    • 33749175714 scopus 로고    scopus 로고
    • Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City
    • Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV, (2006) Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 145: 397-406.
    • (2006) Ann Intern Med , vol.145 , pp. 397-406
    • Sackoff, J.E.1    Hanna, D.B.2    Pfeiffer, M.R.3    Torian, L.V.4
  • 53
    • 0141732110 scopus 로고    scopus 로고
    • Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants
    • Galai N, Safaeian M, Vlahov D, Bolotin A, Celentano DD, (2003) Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants. Am J Epidemiol 158: 695-704.
    • (2003) Am J Epidemiol , vol.158 , pp. 695-704
    • Galai, N.1    Safaeian, M.2    Vlahov, D.3    Bolotin, A.4    Celentano, D.D.5
  • 54
    • 0037446294 scopus 로고    scopus 로고
    • Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use
    • Palepu A, Tyndall M, Yip B, O'Shaughnessy MV, Hogg RS, et al. (2003) Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. J Acquir Immune Defic Syndr 32: 522-526.
    • (2003) J Acquir Immune Defic Syndr , vol.32 , pp. 522-526
    • Palepu, A.1    Tyndall, M.2    Yip, B.3    O'Shaughnessy, M.V.4    Hogg, R.S.5
  • 55
  • 56
    • 15344339904 scopus 로고    scopus 로고
    • Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users
    • Ding L, Landon BE, Wilson IB, Wong MD, Shapiro MF, et al. (2005) Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med 165: 618-623.
    • (2005) Arch Intern Med , vol.165 , pp. 618-623
    • Ding, L.1    Landon, B.E.2    Wilson, I.B.3    Wong, M.D.4    Shapiro, M.F.5
  • 57
    • 77954945992 scopus 로고    scopus 로고
    • Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors
    • Knowlton AR, Arnsten JH, Eldred LJ, Wilkinson JD, Shade SB, et al. (2010) Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors. AIDS Patient Care STDs 24: 421-428.
    • (2010) AIDS Patient Care STDs , vol.24 , pp. 421-428
    • Knowlton, A.R.1    Arnsten, J.H.2    Eldred, L.J.3    Wilkinson, J.D.4    Shade, S.B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.